Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 1/20 | 0.38 |
| ▸ | ACACA | Q13085 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | ACLY | P53396 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28552427 | 0.81 | ACACB (0.41) | ACACBACACATSHRALDH1A1ACLY | |
| SCHEMBL301722 | 0.79 | ACACB (0.40) | ACACBACACATSHRALDH1A1ACLY | |
| SCHEMBL28065512 | 0.77 | ACACB (0.39) | ACACBACACATSHRALDH1A1ACLY | |
| SCHEMBL28065497 | 0.77 | ACACB (0.39) | ACACBACACATSHRALDH1A1ACLY | |
| SCHEMBL17299152 | 0.75 | FDPS (0.41) | ACACBACACATSHRALDH1A1ACLY | |
| SCHEMBL7698226 | 0.75 | ACACB (0.42) | ACACBACACATSHRALDH1A1ACLY | |
| SCHEMBL9688268 | 0.75 | ACACB (0.38) | ACACBACACATSHRALDH1A1ACLY | |
| SCHEMBL17299155 | 0.75 | FDPS (0.41) | ACACBACACATSHRALDH1A1ACLY | |
| SCHEMBL12493645 | 0.75 | FDPS (0.41) | ACACBACACATSHRALDH1A1ACLY | |
| SCHEMBL9710109 | 0.75 | ACACB (0.38) | ACACBACACATSHRALDH1A1ACLY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0124618-A1 | CEPHALOSPORIN DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND AGENTS FOR PROPHYLAXIS OR TREATMENT OF BACTERIA-INDUCED DISEASES | Kyoto Pharmaceutical Industries, Ltd. (JP) | 1984-11-14 | — | — | EP | disclosed |